A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH)Erectile and Sexual Functions and DysfunctionsLower Urinary Tract Symptoms

Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): a post hoc analysis of a prospective randomized placebo-controlled study

Int J Clin Pract.

Rosen RC, Roehrborn CG, Manyak MJ, Palacios-Moreno JM, Wilson TH, Lulic Z, Giuliano F

doi: 10.1111/ijcp.13282.

Benign Prostatic Hyperplasia (BPH)Erectile and Sexual Functions and DysfunctionsLower Urinary Tract Symptoms

Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results from a Prospective FDA-Approved Investigational Device Exemption Study

Urology.

Salem R, Hairston J, Hohlastos E, Riaz A, Kallini J, Gabr A, Ali R, Jenkins K, Karp J, Desai K, Thornburg B, Casalino D, Miller F, Hofer M, Hamoui N, Mouli S

doi: 10.1016/j.urology.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

Eur Urol Focus.

Zumstein V, Betschart P, Vetterlein MW, Kluth LA, Hechelhammer L, Mordasini L, Engeler DS, Kessler TM, Schmid HP, Abt D

doi: 10.1016/j.euf.2018.09.005.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.

Eur Urol.

Dahm P, Brasure M, MacDonald R, Olson CM, Nelson VA, Fink HA, Rwabasonga B, Risk MC, Wilt TJ

doi: 10.1016/j.eururo.2016.09.032.

Benign Prostatic Hyperplasia (BPH)Overactive Bladder

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

J Urol.

Kaplan SA, Herschorn S, McVary KT, Staskin D, Chapple C, Foley S, Cambronero Santos J, Kristy RM, Choudhury N, Hairston J, Schermer CR

doi: 10.1097/JU.0000000000000738.

Benign Prostatic Hyperplasia (BPH)Erectile and Sexual Functions and DysfunctionsLower Urinary Tract Symptoms

Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study

Can J Urol.

Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Herron S, Rashid P, Rukstalis DB

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia

BJU Int.

van der Wijden FC, de Angst IB, Lamers RED, Cuypers M, de Vries M, van Melick HHE, de Beij JS, Oerlemans DJAJ, van de Beek K, Kil PJM

doi: 10.1111/bju.14646.

Benign Prostatic Hyperplasia (BPH)Erectile and Sexual Functions and DysfunctionsLower Urinary Tract Symptoms

Management of lower urinary tract symptoms associated with benign prostatic hyperplasia in elderly patients with a new diagnostic, therapeutic and care pathway

Int J Clin Pract.

Carbone A, Fuschi A, Al Rawashdah SF, Al Salhi Y, Velotti G, Ripoli A, Autieri D, Palleschi G1, Pastore AL

doi: 10.1111/ijcp.12849.

Lower Urinary Tract Symptoms

Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.

J Urol.

Kim JC, Cho KJ, Lee JG, Seo JT, Kim DY, Oh SJ, Lee KS, Choo MS, Lee JZ

doi: 10.1016/j.juro.2016.08.116.

Related content

Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): a post hoc analysis of a prospective randomized placebo-controlled study

Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results from a Prospective FDA-Approved Investigational Device Exemption Study

Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study

Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia

Management of lower urinary tract symptoms associated with benign prostatic hyperplasia in elderly patients with a new diagnostic, therapeutic and care pathway

Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.